Back to Investors
IW Capital

IW Capital

Venture Capital

IW Capital is a UK-based venture capital firm investing in high-growth SMEs. Founded in 2011, the firm backs ambitious entrepreneurs building brilliant technology businesses across the UK.

Portfolio

11

companies


Portfolio companies

AS

Alesi Surgical

Alesi Surgical develops technology to remove hazardous surgical smoke in operating theatres.

Lucida Medical

Lucida Medical

Lucida Medical develops artificial intelligence software to accelerate and improve cancer diagnostics from MRI scans.

N

Navigator

Navigator operates a privacy-first digital advertising platform powered by travel data.

Strolll

Strolll

Strolll provides augmented reality software for neurorehabilitation.

MA

MAGIC AI

Magic AI produces holographic fitness mirrors powered by artificial intelligence.

LL

Location Live

Location Live operates an online marketplace for brands to source activation space globally.

Plumm

Plumm

Plumm offers an integrated software platform delivering corporate mental health support and wellbeing resources.

Situ Live

Situ Live

Situ Live operates experiential product marketing platforms that connect consumers with brands through physical and digital venues.

GPDQ

GPDQ

GPDQ provides primary healthcare services nationwide for the NHS and corporate clients.

U

Ubamarket

Ubamarket provides mobile scan pay go technology for retail stores.

LL

Location Live Group

Location Live Group provides location planning and digital marketplace solutions for the live events sector.


Team

LD

Luke Davis

CEO

Luke brings investment and leadership experience, having previously served as chief executive and founder at IW Capital and on the board of the UK Business Angels Association.

CS

Chris Soames

Investor Director

AP

Alex Petri

Investment Director

CS

Christopher Soames

Investment Director

TA

Tariq Attia

CEO

IE

Isobel Egemole

Investment Director

CL

Charlie Lyon Carroll

Investment Director

AB

Andrew Brode

Investment Committee Member

DF

David Fisher

Senior Investment Director


Recent investments

Series B
£7.0M

The funding round was led by IW Capital with support from existing investors IP Group and Mercia Ventures.

"Electrosurgical tools have transformed modern surgery but also generate surgical smoke that affects the quality and efficiency of surgery and poses risks to operating theatre staff. For years, available solutions have required trade-offs between effectiveness and workflow disruption, slowing adoption across the industry. As awareness grows that smoke management is integral to surgical safety and efficiency, solutions that tackle smoke at its source are becoming increasingly important for supporting the next generation of minimally invasive and robotic procedures."
— Dominic Griffiths, Founder and CEO
£8.7M

The funding round included participation from XTX Ventures and Macmillan Cancer Support to accelerate deployment and expand diagnostics.

"Cancer imaging volumes are rising rapidly but reporting capacity is not keeping pace. Our goal is to give clinicians faster, more confident decisions while reducing unnecessary interventions for patients. With our deep focus on prostate cancer and strong clinical validation across NHS pathways, we’re showing how AI can deliver earlier and more accurate diagnoses. In the NHS, few Trusts can confirm or rule out cancer within 28 days, and some patients can wait two months or longer. Lucida Medical is ideally placed to reduce this burden, and this funding will allow us to do that faster."
— Antony Rix, Co-founder and CEO
£4.0M

IW Capital led the investment round to support product development and commercial scaling.

"Navigator is solving one of the most urgent challenges in digital marketing how to deliver effective advertising in a world where privacy is paramount. With exclusive access to rich data, a proven commercial model, and a leadership team with deep industry experience, Navigator is perfectly positioned to scale. We’re excited to support its next stage of growth."
— Charlie Lyon Carroll, Investment Director
Series A
£10.4M

The Series A round was led by IW Capital and will fund sales growth and product development.

"IW Capital are thrilled to announce our investment into Strolll. Strolll are transforming the physiotherapy and neurorehabilitation markets and have already helped a significant number of people with debilitating neurological disorders to live better lives. The potential impact of their software is huge and we’re proud to be backing this cutting-edge business as it addresses key healthcare needs."
— Isobel Egemole, Investment Director
Seed
£4.0M

IW Capital led the seed investment round to help the fitness technology developer scale operations and expand into new markets.

"AI has evolved chatbots and image generation, but areas such as using it to train in health and wellness are yet to be disrupted. We are proud to have developed the largest exercise tracking detection software of its kind to lead this charge. We have changed the lives of 1,000s of customers over the last 18 months who have collectively logged 46,000 hours of personal training using our innovative AI Mirror and we plan to 5x this over the next year."
— Varun Bhanot, Co-Founder and CEO
Series A
£3.3M

IW Capital backs Location Live with follow-on funding to accelerate international expansion.

"We're very pleased to be Location Live's choice of investor for the second time as the company seeks to grow in international markets. As engaged investors, we have supported Location Live throughout their journey since we initially invested with them in 2022. It speaks volumes about our partnership and the confidence our investors have in the business that we're able to provide follow-on funding for this exciting, innovative, and growing company."
— Christopher Soames, Investment Director
Series A
£2.2M

IW Capital led the Series A round to support team growth and international scaling.

"We’re pleased to be investing in Plumm as the company continues to grow in the UK and internationally. At IW Capital, we focus on backing businesses that are doing important work in growing markets, and it was clear that Plumm is well poised to expand their offering, having built a great platform to serve the underserved and expanding mental health market. We are thrilled to be working with Plumm on the next stage of their growth journey."
— Alex Petri, Investment Director
Other
£1.0M

IW Capital backed the immersive shopping platform in its first investment into the company.

"IW Capital is proud to invest in Situ Live. This investment will enable the company to continue its exponential growth. Situ Live has reinvented the consumer shopping experience by blending traditional and digital retail marketing, encouraging consumers to interact with brands in a whole new way."
— Luke Davis, CEO
£2.6M

IW Capital backs healthcare provider GPDQ with £2.6m to support ongoing expansion.

"IW Capital is proud to invest in GPDQ as the company continues to expand. GPDQ is a market disruptor in the healthcare space. Its phenomenal growth, proven track record, strong client base and plans to maximise growth in the post-Covid world has impressed the team at IW Capital. We are committed to providing GPDQ with the capital to enable them to expand at pace and support them, particularly as there is a growing demand for healthcare services and resources since the pandemic."
— Luke Davis, CEO
Growth
£800K

IW Capital has provided an additional £800k to support the retail technology developer as it scales its operations.

"Ubamarket is disrupting the traditional shopping experience with their Scan Pay Go technology seen across the retail industry today. It has developed a compelling Scan Pay Go app with its patented technology and is now ready to roll out at scale. IW Capital is excited to be backing Ubamarket at a fundamental time as they scale up their technology offering and expand globally. Their technology improves businesses and customer experiences alike."
— Luke Davis, CEO
Series A
£2.0M

The funding round was led by IW Capital to support expansion into international markets and further develop the LO:LIVE platform.

"The clear and defined strategy, the scale of the opportunity and energy and drive from the management of Location Live, made this a very simple decision to invest. Rarely do you see such a transparent opportunity for growth with, with evident market preparedness and matched ambition from the management."
— Chris Soames, Investor Director
Seed
£2.9M

IW Capital led the oversubscribed funding round to support the company as it moves into the hospitality sector.

"We are proud to have so many people have such faith in our service. 2020 was an excellent year for us, building such crucial trade partnerships. Now we are looking to continue 2021 in a similar vein with our bold expansion into the hospitality industry. Through NOMM, we are providing an app that will bring reassurances and comfort to guests and business owners alike. Once the industry is reopened, we will have produced the fastest, cheapest and most tech-enabled solution to many of the problems Covid has highlighted."
— Will Broome, founder and CEO
Series A
£2.0M

The funding round was led by IW Capital to support the expansion of GPDQ as it responds to rising healthcare demand.

"We set out five years ago with a vision to build a more sustainable healthcare system in the UK by working with the NHS, employers and insurers to deliver more care closer to patients out in the community. We’ve worked hard to build a community of clinicians who believe passionately in the ability of technology and new ways of working to achieve that goal. Whether the route to connect is through a visit, in a clinic or over the video, the personal interaction between doctor and patient is at the heart of everything we do."
— Paul Roberts, CEO and Co-Founder